VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HNSTThe Honest Company, Inc.
$3.60$396M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. HNST
  4. Financial Ratios

The Honest Company, Inc. (HNST) Financial Ratios

Latest Ratios: P/E Ratio -25.7x · EV/EBITDA N/A · ROE -9.1%. (2019–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

HNST Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Market Cap$396M$287M$695M$312M$278M$575M——
Enterprise Value$312M$202M$641M$309M$306M$562M——
P/E Ratio →-25.71———————
P/S Ratio1.070.771.840.910.881.81——
P/B Ratio2.361.693.992.531.903.21——
P/FCF29.1121.08687.1417.82————
P/OCF26.2118.97450.8116.12————

P/E links to full P/E history page with 30-year chart

HNST EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
EV / Revenue—0.541.690.900.971.76——
EV / EBITDA——216.85—————
EV / EBIT————————
EV / FCF—14.86634.0317.65————

HNST Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Gross Margin33.3%33.3%38.2%29.2%29.4%34.3%35.9%32.2%
Operating Margin-5.0%-5.0%-1.7%-11.3%-15.9%-11.6%-4.5%-13.4%
Net Profit Margin-4.2%-4.2%-1.6%-11.4%-15.6%-12.1%-4.8%-13.2%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
ROE-9.1%-9.1%-4.1%-29.1%-30.1%-21.6%——
ROA-6.6%-6.6%-2.7%-17.7%-19.1%-15.1%-6.1%-13.3%
ROIC-13.5%-13.5%-3.9%-19.8%-21.9%-16.7%——
ROCE-10.2%-10.2%-3.8%-24.2%-24.8%-17.9%-7.1%-16.1%

HNST Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Debt / Equity0.030.030.120.240.260.21——
Debt / EBITDA——7.35—————
Net Debt / Equity—-0.50-0.31-0.020.19-0.07——
Net Debt / EBITDA——-18.17—————
Debt / FCF—-6.22-53.11-0.17————
Interest Coverage-4.20-4.20—-144.59—-21.00-16.18—

Net cash position: cash ($90M) exceeds total debt ($5M)

HNST Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Current Ratio3.983.983.572.782.974.413.214.34
Quick Ratio2.562.562.151.491.162.851.792.98
Cash Ratio1.761.761.260.580.241.921.182.20
Asset Turnover—1.651.531.711.301.171.251.01
Inventory Turnover3.413.412.743.321.912.772.513.04
Days Sales Outstanding—33.1941.9445.6749.2636.4127.6937.58

HNST Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Dividend Yield—————6.1%——
Payout Ratio————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Earnings Yield————————
FCF Yield3.4%4.7%0.1%5.6%————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%——
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%6.1%——
Shares Outstanding—$111M$100M$95M$92M$71M$90M$90M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Persistent Revenue Contraction

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Skepticism Regarding Growth Recovery

Based on current market data, the company trades at a P/S multiple of 1.07, which appears to reflect significant investor doubt regarding the firm's ability to return to sustainable growth, especially when contrasted with the premium multiples often assigned to high-growth wellness and consumer brands.

The forward P/E of 51.43 suggests that the market is pricing in a substantial recovery in earnings that has yet to materialize in the operational results. Investors should monitor whether this valuation is supported by a genuine turnaround in retail velocity or if it remains a speculative premium based on the brand's niche market position.

Capital Efficiency Remains Structurally Challenged

As reported in recent financial statements, the company's ROIC has struggled to maintain positive territory, oscillating around -0.6% in 2026Q1, which indicates that the firm is currently failing to generate returns that exceed its cost of capital, thereby eroding shareholder value over the long term.

The inability to consistently achieve positive ROIC suggests that the company's investments in brand equity and omnichannel distribution have not yet reached the necessary scale to drive efficient returns. This trend warrants further investigation into whether the current business model can ever achieve the capital efficiency seen in more mature, high-margin consumer goods peers.

Working Capital Cycles Indicate Inefficiency

According to the company's quarterly filings, the cash conversion cycle has remained elevated, reaching 143 days in 2026Q1, a figure that highlights significant friction in inventory management and suggests that capital remains tied up in slow-moving stock rather than being deployed for growth.

The high days inventory outstanding (DIO) of 134 days relative to the industry average suggests that the company may be over-ordering or facing weaker-than-expected sell-through at retail partners. This inefficiency forces the company to maintain higher liquidity levels than would otherwise be necessary, effectively acting as a drag on overall operational performance.

Minimal Debt Provides Defensive Buffer

Based on the company's reported figures, the debt-to-equity ratio of 0.02% demonstrates a remarkably clean balance sheet, which serves as a critical defensive asset that insulates the firm from the interest rate volatility currently impacting more highly leveraged competitors in the specialty retail sector.

While the lack of debt provides significant financial flexibility, it also suggests that the company has not utilized leverage to accelerate growth, perhaps reflecting management's cautious approach to capital allocation. Investors should monitor whether this conservative stance is a strategic choice to preserve runway or a missed opportunity to invest in brand expansion during a critical lifecycle phase.

Misapplication of Revenue Growth Metrics

Analysts frequently misapply top-line revenue growth as a primary indicator of health for this business, failing to account for the significant impact of trade spend and promotional discounting that often masks the true underlying demand for the company's premium-priced wellness products.

A more accurate assessment would involve focusing on net revenue per customer or gross margin expansion, as these metrics better reflect the brand's pricing power and the effectiveness of its omnichannel strategy. Relying solely on headline revenue growth may obscure the reality that the company is essentially buying market share through unsustainable promotional activity.

Download Financial Ratios Data

Includes 30+ ratios · 7 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HNST — Frequently Asked Questions

Quick answers to the most common questions about buying HNST stock.

What is The Honest Company, Inc.'s P/E ratio?

The Honest Company, Inc.'s current P/E ratio is -25.7x. This places it at the 50th percentile of its historical range.

What is The Honest Company, Inc.'s ROE?

The Honest Company, Inc.'s return on equity (ROE) is -9.1%. The historical average is -18.8%.

Is HNST stock overvalued?

Based on historical data, The Honest Company, Inc. is trading at a P/E of -25.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are The Honest Company, Inc.'s profit margins?

The Honest Company, Inc. has 33.3% gross margin and -5.0% operating margin.